VYLOY subst seche 300 mg 1 pce

7680695010039 CH-69501 L01FX31 07.16.1.

No images available

Details

Product number
6950102
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
zolbetuximabum 300 mg, argininum, acidum phosphoricum ad pH, saccharum, polysorbatum 80, pro vitro.

Articles (1)

Vyloy 300 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
zolbetuximabum
300.0 MG Substance Wirkstoff (Principe actif)
argininum
- Substance HNIDK
acidum phosphoricum
- Substance HNIDK
saccharum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK

Authorization holder

Astellas Pharma AG

8304 Wallisellen

Authorization information

Swissmedic authorization number
69501
Drug name
Vyloy, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Galenic form
PULPI
ATC Code
L01FX31
Authorization status
Z
Dispensation category
A
First authorization
19/02/2025
Authorization expiration date
18/02/2030
IT number
07.16.1.
Domain
Human medicine
Field of application
Magenkarzinom

Packaging details

Description (FR)
VYLOY subst seche 300 mg 1 pce
Description (DE)
VYLOY Trockensub 300 mg 1 Stk
Market launch
03/06/2026
Narcotic (BTM)
No

Other packaging sizes

VYLOY subst sèche 100 mg flac
1 DUR
GTIN: 7680695010015
View
VYLOY subst sèche 100 mg flac 3 pce
3 DUR
GTIN: 7680695010022
View
Buy us a coffee Explore the data